FDA approved avatrombopag for thrombocytopenia in CLD patients scheduled for a procedure
- On May 21, the FDA approved avatrombopag (DopteletⓇ, AkaRx Inc.) for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) scheduled to undergo a procedure.
Trackbacks & Pingbacks
[…] post FDA approved avatrombopag for thrombocytopenia in CLD patient scheduled for a procedure appeared first on Medical Writer Agency | 香港醫學作家 | MediPR | MediPaper Hong […]
Leave a Reply
Want to join the discussion?Feel free to contribute!